SCHEMBL30735562

SCHEMBL30735562

NC(=O)NC1CCN(c2cccc3ccccc23)CC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SIGMAR1 Q99720 3/20 0.49
▸ HTR1A P08908 2/20 0.49
▸ HTR2A P28223 2/20 0.49
▸ HTR3E A5X5Y0 1/20 0.49
▸ HTR3B O95264 1/20 0.49
▸ CYP1A2 P05177 1/20 0.49
▸ CYP2D6 P10635 1/20 0.49
▸ NCF1 P14598 1/20 0.49
▸ TSHR P16473 1/20 0.49
▸ NFKB1 P19838 1/20 0.49
▸ HTR1D P28221 1/20 0.49
▸ HTR1B P28222 1/20 0.49
▸ HTR7 P34969 1/20 0.49
▸ MTOR P42345 1/20 0.49
▸ HTR3A P46098 1/20 0.49
▸ HTR5A P47898 1/20 0.49
▸ HTR6 P50406 1/20 0.49
▸ HTR3D Q70Z44 1/20 0.49
▸ HTR3C Q8WXA8 1/20 0.49
▸ HSD17B10 Q99714 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19284737 1.00 SIGMAR1 (0.49) SIGMAR1HTR1AHTR2AHTR3EHTR3B
SCHEMBL30735592 0.86 CKS1B (0.51) SIGMAR1HTR1AHTR2AHTR3EHTR3B
SCHEMBL19284732 0.86 CKS1B (0.51) SIGMAR1HTR1AHTR2AHTR3EHTR3B
SCHEMBL27740410 0.82 GAA (0.55) HTR1AHSD17B10KDM4EALDH1A1HPGD
SCHEMBL22719780 0.82 TGM2 (0.52) SIGMAR1HTR1AHTR2AHTR3EHTR3B
SCHEMBL29505173 0.82 TGM2 (0.52) SIGMAR1HTR1AHTR2AHTR3EHTR3B
SCHEMBL19284706 0.80 CKS1B (0.57) DRD2DRD3
SCHEMBL17846438 0.77 EPHX2 (0.58) TSHRALDH1A1DRD2DRD3EPHX1
SCHEMBL19284691 0.77 HTR1A (0.59) SIGMAR1HTR1AHTR2AHTR3EHTR3B
SCHEMBL9768355 0.77 HTR1A (0.59) SIGMAR1HTR1AHTR2AHTR3EHTR3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11891369-B2 Compounds for binding proprotein convertase subtilisin/kexin type 9 SRX CARDIO, LLC (US) 2024-02-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11891369-B2 Compounds for binding proprotein convertase subtilisin/kexin type 9 PCSK9, PCSK6, PCSK7 SIGMAR1 4853/4885HTR1A 3211/4885HTR2A 3383/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback